|
Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation
|
4R44CA203336-02
|
$659,516
|
|
AGUILAR-CORDOVA, ESTUARDO
|
ADVANTAGENE, INC
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
7R01CA182076-05
|
$339,622
|
|
ALLEN, PETER
|
DUKE UNIVERSITY
|
|
Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer
|
4R00CA204593-03
|
$249,000
|
|
ALTMAN, BRIAN
|
UNIVERSITY OF ROCHESTER
|
|
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence
|
3R01CA208042-03S1
|
$223,893
|
|
ALVAREZ, JAMES
|
DUKE UNIVERSITY
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$461,571
|
$461,571
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Regulation and Consequences of Ubiquitination
|
ZIA BC 010779
|
$230,786
|
$46,157
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Glucocorticoids and T cell development and function
|
ZIA BC 011264
|
$230,786
|
$230,786
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Multiple Myeloma - Yale case-control
|
ZIA CP010123 - 02380
|
$5,010
|
$250
|
Baris, Dalsu
|
DCEG (NCI)
|
|
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries
|
4UH3CA202721-03
|
$513,260
|
|
BASU, PARTHA
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
Administrative Supplement to Cancer Center Support Grant to Support Acquisition and Annotation of Biospecimens
|
3P30CA022453-36S5
|
$46,200
|
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
AN IMAGING-BASED APPROACH TO UNDERSTAND AND PREDICT CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY
|
3R01CA208623-02S3
|
$168,645
|
|
BEREZIN, MIKHAIL
|
WASHINGTON UNIVERSITY
|
|
Permethrin exposure in NHANES
|
ZIA CP010125 - 10695
|
$11,399
|
$1,140
|
Berndt, Sonja
|
DCEG (NCI)
|
|
PLCO - Lymphoma
|
ZIA CP010152 - 10709
|
$80,240
|
$20,060
|
Berndt, Sonja
|
DCEG (NCI)
|
|
Molecular Imaging of Cachexia in Pancreatic Cancer
|
3R01CA193365-03S1
|
$163,675
|
|
BHUJWALLA, ZAVER
|
JOHNS HOPKINS UNIVERSITY
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S3
|
$91,218
|
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S4
|
$45,500
|
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Molecular Mechanism of Action of Phorbol Ester
|
ZIA BC 005270
|
$1,507,268
|
$226,090
|
Blumberg, Peter
|
CCR (NCI)
|
|
TARGETING APOBEC3A-EXPRESSING CANCER CELLS WITH ATR INHIBITORS
|
4R00CA212154-03
|
$249,000
|
|
BUISSON, REMI
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Role of KLHL6 inactivation in mature B-cell malignancies
|
3R01CA207513-03S1
|
$262,183
|
|
BUSINO, LUCA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5
|
5R01CA170653-04
|
$581,173
|
$145,293
|
BYERS, STEPHEN
|
GEORGETOWN UNIVERSITY
|
|
Investigating Fatty Acid Oxidation in Primary and Metastatic MYC-Overexpressing Triple-Negative Breast Cancer
|
4K00CA212488-03
|
$73,386
|
|
CAMARDA, ROMAN
|
BUCK INSTITUTE FOR RESEARCH ON AGING
|
|
Families at high risk of cancer
|
ZIA CP004410 - 08285
|
$1,104,439
|
$165,666
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Familial aspects of Waldenstrom's macroglobulinemia
|
ZIA CP004410 - 08300
|
$239,304
|
$71,791
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$811,586
|
$81,159
|
Carrington, Mary
|
CCR (NCI)
|
|
Characterization of recurrent cancer mutations that cause misregulated translation
|
4R00CA204522-03
|
$248,999
|
|
CENIK, CAN
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
Hemodynamic Noninvasive Skin Cancer Diagnostics
|
3R44CA203038-03S1
|
$2,000
|
|
CHACHISVILIS, MIRIANAS
|
VERISKIN, INC.
|
|
The Radiation Planning Assistant (RPA) for Radiation Therapy Planning in Low- and Middle-Income Countries
|
4UH3CA202665-03
|
$871,514
|
|
COURT, LAURENCE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Chronic graft-versus-host disease
|
ZIA BC 011549
|
$169,809
|
$169,809
|
Cowen, Edward
|
CCR (NCI)
|
|
Anakinra for neutrophilic pustular skin disease
|
ZIA BC 011550
|
$254,713
|
$229,242
|
Cowen, Edward
|
CCR (NCI)
|
|
Engineering enzymatic activity of a cancer therapeutic tospecifically target extracellular matrix in the tumor microenvironment
|
3R43CA224705-01S1
|
$149,008
|
|
CROSTON, GLENN
|
PHENZYME, INC.
|
|
Affective Consequences of Chemotherapy
|
7R01CA194924-04
|
$396,867
|
|
DEVRIES, ANNE
|
WEST VIRGINIA UNIVERSITY
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-44S2
|
$171,085
|
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Cytokines and T Cell Development
|
ZIA BC 009287
|
$474,529
|
$94,906
|
Durum, Scott
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA091842-17S2
|
$254,917
|
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010150 - 10359
|
$270,757
|
$27,076
|
Engels, Eric
|
DCEG (NCI)
|
|
Early Stage Diagnosis of Kaposis Sarcoma in Limited Resource Settings using KS-Detect
|
4UH3CA202723-03
|
$993,475
|
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-06S1
|
$101,000
|
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-06S2
|
$241,905
|
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
Cancer Center Support Grant 2018-2023
|
3P30CA046592-29S1
|
$60,000
|
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Cancer Center Support Grant 2018-2023
|
3P30CA046592-29S2
|
$249,249
|
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The Impact of Tobacco Control Policies on Health Equity in the United States
|
3R37CA214787-01A1S1
|
$57,840
|
|
FLEISCHER, NANCY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A Scalable Blood-based Pancreatic Cancer Test for High-Risk Screening
|
3R43CA213863-01A1S1
|
$2,000
|
|
FREEDMAN, DAVID
|
NANOVIEW DIAGNOSTICS, INC.
|
|
Diet and obesity related exposures in SEER-Medicare
|
ZIA CP010127 - 10573
|
$17,677
|
$884
|
Freedman, Neal
|
DCEG (NCI)
|
|
Mechanism of myeloid cell defect in cancer
|
3R01CA100062-14S1
|
$178,200
|
|
GABRILOVICH, DMITRY
|
WISTAR INSTITUTE
|
|
CPRD: UK Resource for Epidemiologic Research
|
ZIA CP010144 - 10722
|
$92,758
|
$92,758
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
The Role of PHLPP in Colon Cancer
|
3R01CA133429-11S1
|
$138,690
|
|
GAO, TIANYAN
|
UNIVERSITY OF KENTUCKY
|
|
Contribution of Gynecologic and Breast Cancer Biospecimens from African American women to HCMI
|
3P30CA043703-28S2
|
$48,000
|
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice
|
3R01CA193244-08S1
|
$171,500
|
|
GHOSHAL, KALPANA
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA015704-43S4
|
$225,000
|
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Autoimmune Diseases for this search: $6,764,912
|